Consortium for Broad Based Disease Phenotyping of Knockout Mice
基因敲除小鼠广泛疾病表型联盟
基本信息
- 批准号:8333401
- 负责人:
- 金额:$ 264.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-09-16 至 2016-07-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAnimal ModelAreaBiochemical PathwayBiological AssayCardiovascular systemCommunitiesCystic FibrosisDataData Coordinating CenterData QualityData SetDevelopmentDiseaseEnsureFundingFutureGenesGeneticGenetic ProgrammingGoalsHealthHumanHuman GeneticsInbred StrainInstitutesInternationalInvestigationKnockout MiceKnowledgeLaboratoriesLearningMalignant NeoplasmsMammalian GeneticsMeasurementMedicalMedical ResearchMedicineMetabolicMorbidity - disease rateMusMutant Strains MiceNeurologicPersonsPhenotypePhysiologicalPilot ProjectsPre-Clinical ModelResearchResearch PersonnelResourcesScienceScientistSensitivity and SpecificityStressSymptomsSystemTexasTherapeuticTrustUnited KingdomWorkbasecollegedesigndisease phenotypeembryonic stem cellexperiencegene functiongenetic varianthigh throughput screeningimprovedinterestmembermouse genomemouse modelmutantnovelnovel strategiesoperationpleiotropismrespiratorytool
项目摘要
DESCRIPTION (provided by applicant): A comprehensive functional annotation of all genes is a key goal for the future investigation of mammalian systems and biomedical sciences. We have established a consortium for the large-scale phenotyping of mouse mutants, which is fundamental to the investigation of gene function. The BaSH consortium, Baylor College of Medicine (BCM), Houston, Texas, the Wellcome Trust Sanger Institute Mouse Genetics Programme, Hinxton, United Kingdom, and the Medical Research Council Harwell, (Mammalian Genetics Unit and Mary Lyon Centre), United Kingdom, will undertake broad-based phenotype analysis of 300 IKMC mouse lines per year with the aim of identifying perturbations on developmental, physiological and biochemical pathways that will guide experimenters to develop hypothesis-driven research into disease systems. Our aims are to 1) complete the broad-based disease phenotyping of over 1500 lines of mutant mice in the C57BL/6N genetic background, 2) validate an optimized and enhanced broad-based phenotyping pipeline that will detect a variety of disease phenotypes and increase throughput, and 3) submit phenotypic data to the designated data coordination center, ensuring an interface with the wider biomedical scientific community that will inform human genetic studies. Our approach is to build on our unique expertise in mouse phenotyping and the successful operation of major pilot projects for mouse phenotyping of EUCOMM and KOMP mutants to deliver a phenotyping pipeline with strategic breadth that serves the needs of the medical community. Our pipeline design aims to deliver mouse models in key therapeutically relevant areas - for example in Cardiovascular, Metabolic, Neurological, Respiratory and Immunological Systems. Assessment of mouse mutants using our phenotyping pipeline will discover novel preclinical models of therapeutic importance, encompassing many of the diseases that account for the highest rates of disease morbidity throughout the developed world.
RELEVANCE: Most of the genes in a person are normal, but we also carry several hundred broken ones. While some broken genes can cause severe disease such as cystic fibrosis or cancer, others have little of no consequence, or function only under stress. Currently, we have some understanding of the function of just one third of human genes. If we are to fully understand human health and disease we must expand knowledge of gene function to all of our genes using model organisms such as the mouse.
描述(由申请人提供):所有基因的全面功能注释是对哺乳动物系统和生物医学科学的未来研究的关键目标。我们已经建立了一个用于小鼠突变体大规模表型的联盟,这是基因功能研究的基础。 BASH联盟,贝勒医学院(BCM),德克萨斯州休斯敦,惠康信托基金会桑格研究所鼠标遗传学计划,欣克斯顿,英国,英国和医学研究委员会Harwell(英国哺乳动物遗传学单位和玛丽·里昂中心),英国,将对300 IKMC鼠标的基于较广泛的表型分析,并将对300 IKMC鼠标的广泛分析进行,并将生化途径将指导实验者开发以假设为导向疾病系统的研究。 Our aims are to 1) complete the broad-based disease phenotyping of over 1500 lines of mutant mice in the C57BL/6N genetic background, 2) validate an optimized and enhanced broad-based phenotyping pipeline that will detect a variety of disease phenotypes and increase throughput, and 3) submit phenotypic data to the designated data coordination center, ensuring an interface with the wider biomedical scientific community that will inform human genetic studies.我们的方法是基于我们在鼠标表型中的独特专业知识以及主要试点项目的成功运作,用于鼠标和科普突变体的鼠标表型,以提供具有策略广度的表型管道,以满足医疗社区需求。我们的管道设计旨在在关键的治疗领域提供小鼠模型,例如在心血管,代谢,神经系统,呼吸系统和免疫系统中。使用我们的表型管道对小鼠突变体进行评估将发现治疗重要性的新型临床前模型,其中包括许多疾病,这些疾病是整个发达国家疾病发病率最高的疾病。
相关性:一个人中的大多数基因都是正常的,但我们也携带了数百个基因。尽管某些破裂的基因会引起严重的疾病,例如囊性纤维化或癌症,但其他基因几乎没有任何后果,或者仅在压力下起作用。目前,我们对仅三分之一的人类基因的功能有所了解。如果我们要充分了解人类健康和疾病,则必须使用小鼠等模型生物扩大对所有基因的知识。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MONICA J. JUSTICE其他文献
MONICA J. JUSTICE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MONICA J. JUSTICE', 18)}}的其他基金
The pluripotency regulator Prdm14 initiates cancer by epigenetic mechanisms
多能性调节因子 Prdm14 通过表观遗传机制引发癌症
- 批准号:
8844112 - 财政年份:2014
- 资助金额:
$ 264.2万 - 项目类别:
The pluripotency regulator Prdm14 initiates cancer by epigenetic mechanisms
多能性调节因子 Prdm14 通过表观遗传机制引发癌症
- 批准号:
9267938 - 财政年份:2014
- 资助金额:
$ 264.2万 - 项目类别:
The pluripotency regulator Prdm14 initiates cancer by epigenetic mechanisms
多能性调节因子 Prdm14 通过表观遗传机制引发癌症
- 批准号:
8898738 - 财政年份:2014
- 资助金额:
$ 264.2万 - 项目类别:
The pluripotency regulator Prdm14 initiates cancer by epigenetic mechanisms
多能性调节因子 Prdm14 通过表观遗传机制引发癌症
- 批准号:
8583023 - 财政年份:2013
- 资助金额:
$ 264.2万 - 项目类别:
Consortium for Broad Based Disease Phenotyping of Knockout Mice
基因敲除小鼠广泛疾病表型联盟
- 批准号:
8626464 - 财政年份:2011
- 资助金额:
$ 264.2万 - 项目类别:
Consortium for Broad Based Disease Phenotyping of Knockout Mice
基因敲除小鼠广泛疾病表型联盟
- 批准号:
8189488 - 财政年份:2011
- 资助金额:
$ 264.2万 - 项目类别:
Consortium for large-scale production and cryopreservation of knockout mice
基因敲除小鼠大规模生产和冷冻保存联盟
- 批准号:
8189478 - 财政年份:2011
- 资助金额:
$ 264.2万 - 项目类别:
CONSORTIUM FOR LARGE-SCALE PRODUCTION AND CRYOPRESERVATION KNOCKOUT MICE: AIDS
大规模生产和低温保存敲除小鼠联盟:艾滋病
- 批准号:
8356913 - 财政年份:2011
- 资助金额:
$ 264.2万 - 项目类别:
Consortium for large-scale production and cryopreservation of knockout mice
基因敲除小鼠大规模生产和冷冻保存联盟
- 批准号:
8325929 - 财政年份:2011
- 资助金额:
$ 264.2万 - 项目类别:
CONSORTIUM FOR LARGE-SCALE PRODUCTION AND CRYOPRESERVATION OF KNOCKOUT MICE
基因敲除小鼠大规模生产和冷冻保存联盟
- 批准号:
8356914 - 财政年份:2011
- 资助金额:
$ 264.2万 - 项目类别:
相似国自然基金
髋关节撞击综合征过度运动及机械刺激动物模型建立与相关致病机制研究
- 批准号:82372496
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
利用碱基编辑器治疗肥厚型心肌病的动物模型研究
- 批准号:82300396
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
利用小型猪模型评价动脉粥样硬化易感基因的作用
- 批准号:32370568
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
丁苯酞通过调节细胞异常自噬和凋亡来延缓脊髓性肌萎缩症动物模型脊髓运动神经元的丢失
- 批准号:82360332
- 批准年份:2023
- 资助金额:31.00 万元
- 项目类别:地区科学基金项目
APOBEC3A驱动膀胱癌发生发展的动物模型及其机制研究
- 批准号:82303057
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
Transcranial Ultrasound Algorithms and Device for Rapid Stroke Determination by Paramedics
用于医护人员快速确定中风的经颅超声算法和设备
- 批准号:
10730722 - 财政年份:2023
- 资助金额:
$ 264.2万 - 项目类别:
CSRD Research Career Scientist Award Application
CSRD研究职业科学家奖申请
- 批准号:
10701136 - 财政年份:2023
- 资助金额:
$ 264.2万 - 项目类别:
Evolution of Mayaro virus and its impact on transmission by urban vectors
马亚罗病毒的进化及其对城市媒介传播的影响
- 批准号:
10753968 - 财政年份:2023
- 资助金额:
$ 264.2万 - 项目类别:
Metabolic Phenotyping in Live Models of Obesity and Diabetes
肥胖和糖尿病活体模型的代谢表型分析
- 批准号:
10588794 - 财政年份:2023
- 资助金额:
$ 264.2万 - 项目类别:
Characterization of aneuploidy, cell fate and mosaicism in early development
早期发育中非整倍性、细胞命运和嵌合体的表征
- 批准号:
10877239 - 财政年份:2023
- 资助金额:
$ 264.2万 - 项目类别: